A double-blind, randomized, placebo controlled, parallel group study to compare the safety and efficacy of an olmesartan medoxomil based treatment regimen to placebo in patients with stage I and stage II hypertension.

Trial Profile

A double-blind, randomized, placebo controlled, parallel group study to compare the safety and efficacy of an olmesartan medoxomil based treatment regimen to placebo in patients with stage I and stage II hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Hydrochlorothiazide
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 26 Jan 2010 Actual patient number (278) added as reported by ClinicalTrials.gov.
    • 26 Jan 2010 Actual end date (October 2007) added as reported by ClinicalTrials.gov.
    • 10 Dec 2007 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top